TY - JOUR UR - http://lib.ugent.be/catalog/pug01:203219 ID - pug01:203219 LA - eng TI - Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus PY - 1993 JO - (1993) VACCINE SN - 0264-410X PB - 1993 AU - Vanlandschoot, Peter AU - Maertens, Geert AU - Min Jou, Willy UGent 801000153237 AU - Fiers, Walter 801000033706 AB - Balb/c mice were immunized with 2 x 2 mug of purified recombinant secreted haemagglutinin, derived from the A/Victoria/3/75 (H3N2) virus. In the first immunization, Ribi adjuvant was used, while for the booster injection a monophosphoryl lipid A/muramyl dipeptide combination was chosen. Mice immunized in this way were 90-100% protected against a challenge with 20 LD50 of mouse-adapted, homologous virus (strain X47). Bromelain-solubilized haemagglutinin gave only 70% protection under comparable conditions. ER -Download RIS file
00000nam^a2200301^i^4500 | |||
001 | 203219 | ||
005 | 20180813141336.0 | ||
008 | 040114s1993------------------------eng-- | ||
022 | a 0264-410X | ||
024 | a A1993LZ90800002 2 wos | ||
024 | a 1854/LU-203219 2 handle | ||
024 | a 10.1016/0264-410X(93)90040-5 2 doi | ||
040 | a UGent | ||
245 | a Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus | ||
246 | a Recombinant secreted hemagglutinin protects mice against a lethal challenge of influenza virus | ||
260 | c 1993 | ||
520 | a Balb/c mice were immunized with 2 x 2 mug of purified recombinant secreted haemagglutinin, derived from the A/Victoria/3/75 (H3N2) virus. In the first immunization, Ribi adjuvant was used, while for the booster injection a monophosphoryl lipid A/muramyl dipeptide combination was chosen. Mice immunized in this way were 90-100% protected against a challenge with 20 LD50 of mouse-adapted, homologous virus (strain X47). Bromelain-solubilized haemagglutinin gave only 70% protection under comparable conditions. | ||
598 | a A1 | ||
700 | a Vanlandschoot, Peter 0 801000900440 9 74B198FC-B25E-11E6-B104-2D2FD0AF0289 | ||
700 | a Maertens, Geert | ||
700 | a Min Jou, Willy u UGent 0 801000153237 0 976164358383 9 F33F9A8E-F0ED-11E1-A9DE-61C894A0A6B4 | ||
700 | a Fiers, Walter 0 801000033706 0 811000033787 9 FC58B20E-F0ED-11E1-A9DE-61C894A0A6B4 | ||
650 | a Biology and Life Sciences | ||
653 | a HEMAGGLUTININ | ||
653 | a INFLUENZA VIRUS | ||
653 | a RECOMBINANT | ||
653 | a PROTECTION | ||
653 | a RIBI ADJUVANT | ||
653 | a VACCINE | ||
653 | a A H1N1 | ||
653 | a HEMAGGLUTININ | ||
653 | a GENE | ||
653 | a HA | ||
773 | t VACCINE g Vaccine. 1993. 11 (12) p.1185-1187 q 11:12<1185 | ||
856 | 3 Full Text u https://biblio.ugent.be/publication/203219/file/938475 z [ugent] y 0777_93Vanlandschoot.pdf | ||
920 | a article | ||
Z30 | x WE 1 WE14 | ||
922 | a UGENT-WE |
All data below are available with an Open Data Commons Open Database License. You are free to copy, distribute and use the database; to produce works from the database; to modify, transform and build upon the database. As long as you attribute the data sets to the source, publish your adapted database with ODbL license, and keep the dataset open (don't use technical measures such as DRM to restrict access to the database).
The datasets are also available as weekly exports.